Silence Therapeutics Plc - American Depository Share revenue breakdown overview

Silence Therapeutics Plc - American Depository Share revenue for the last year amounted to 32.30 M USD, the most of which — 17.01 M USD — came from its highest performing source at the moment, Research Collaboration - AstraZeneca, the year earlier bringing 6.26 M USD. The greatest contribution to the revenue figure was made by United Kingdom — last year it brought Silence Therapeutics Plc - American Depository Share 30.84 M USD, and the year before that — 20.85 M USD.